DURAK, A. Et Al. 2018. A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats. Cardiovascular Diabetology , vol.17, no.1 .

DURAK, A., OLĞAR, Y., DEĞİRMENCİ, S., AKKUŞ, E., TUNCAY, E., & TURAN, B., (2018). A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats. Cardiovascular Diabetology , vol.17, no.1.

DURAK, AYŞEGÜL Et Al. "A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats," Cardiovascular Diabetology , vol.17, no.1, 2018

DURAK, AYŞEGÜL Et Al. "A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats." Cardiovascular Diabetology , vol.17, no.1, 2018

DURAK, A. Et Al. (2018) . "A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats." Cardiovascular Diabetology , vol.17, no.1.

@article{article, author={AYŞEGÜL DURAK Et Al. }, title={A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats}, journal={Cardiovascular Diabetology}, year=2018}